Showing results (281-290 of 344) with videos related to
Sort By:
Pageof 35
Lung Cancer (Amsterdam, Netherlands)|March 26, 2013
Clinical applicability of staging small cell lung cancer according to the seventh edition of the TNM staging systemByung Woo Jhun, Kyung-Jong Lee, Kyeongman Jeon, et al.Cancer|October 16, 2023
Biomarker-driven phase 2 umbrella trial: Clinical efficacy of olaparib monotherapy and combination with ceralasertib (AZD6738) in small cell lung cancerSehhoon Park, Yu Jung Kim, Young Joo Min, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 1, 2017
Randomized Phase II Trial Comparing Chemoradiotherapy with Chemotherapy for Completely Resected Unsuspected N2-Positive Non-Small Cell Lung CancerJong-Mu Sun, Jae Myung Noh, Dongryul Oh, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 28, 2022
A Phase 2 Study of Palbociclib for Recurrent or Refractory Advanced Thymic Epithelial Tumors (KCSG LU17-21)Hyun Ae Jung, Miso Kim, Hae Su Kim, et al.European Journal of Cancer (Oxford, England : 1990)|July 17, 2012
A prospective multicentre phase II study of cisplatin and weekly docetaxel as first-line treatment for recurrent or metastatic nasopharyngeal cancer (KCSG HN07-01)Jun Ho Ji, , Tak Yun, et al.Lung Cancer (Amsterdam, Netherlands)|November 7, 2025
Phase II study of lazertinib and pemetrexed in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer with leptomeningeal metastases: the KCSG LU 21-01, LAZARUS studyHyun Ae Jung, Tae Min Kim, Hye Ryun Kim, et al.Genomics|February 26, 2013
Multiplexed deep sequencing analysis of ALK kinase domain identifies resistance mutations in relapsed patients following crizotinib treatmentDonghui Huang, Dong-Wan Kim, Athanasios Kotsakis, et al.Anticancer Research|November 14, 2013
High-throughput molecular genotyping for small biopsy samples in advanced non-small cell lung cancer patientsChi Hoon Maeng, Ho Yun Lee, Young Wook Kim, et al.Cancer Research and Treatment|July 13, 2010
Predictive value of the ERCC1 expression for treatment response and survival in advanced gastric cancer patients receiving cisplatin-based first-line chemotherapyJina Yun, Kyoung-Mee Kim, Seung Tae Kim, et al.Human Genetics|August 26, 2011
The 18p11.22 locus is associated with never smoker non-small cell lung cancer susceptibility in Korean populationsMyung-Ju Ahn, Hong-Hee Won, Jeeyun Lee, et al.Pageof 35